...
首页> 外文期刊>Dyes and Pigments >A lysosome-localized thionaphthalimide as a potential heavy-atom-free photosensitizer for selective photodynamic therapy
【24h】

A lysosome-localized thionaphthalimide as a potential heavy-atom-free photosensitizer for selective photodynamic therapy

机译:溶酶体局部局部化的硫代视亚胺,作为选择性光动力疗法的潜在重度原子光敏剂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A novel sulfur-substituted naphthalimide (LSNI-S) was synthesized and investigated as a promising lysosome-targeting photosensitizer for photodynamic cancer therapy. The introduction of a dual-functional morpholine group to the 4-position of the naphthalimide backbone combined with the substitution of oxygen atoms by sulfur atoms could facilitate intersystem crossing from the excited singlet state to the reactive triplet state, leading to an excellent singlet oxygen generation efficiency of LSNI-S in organic solvents (Phi(Delta) approximate to 0.84 in air-saturated acetonitrile). Interestingly, LSNI-S could produce reactive oxygen species via both type-I and type-II mechanisms under physiological conditions. In particular, cell studies demonstrated that LSNI-S selectively localizes in lysosomes of cancer cells and exhibits excellent photodynamic therapy efficacy.
机译:合成了一种新型硫取代的萘亚胺(LSNI-S)并作为光动力学癌症治疗的有希望的溶酶体靶向光敏剂研究。 通过硫原子替代氧亚胺骨架的4位与氧原子取代的双官能吗啉基团的引入可以促进从激发的单线状态到反应性三重态的界面交叉,导致优异的速度氧气产生 LSNI-S在有机溶剂中的效率(PHI(δ)近似到0.84的空饱和乙腈)。 有趣的是,LSNI-S可以通过生理条件下的I型和II型机制产生活性氧物质。 特别地,细胞研究表明,LSNI-S选择性地定位在癌细胞的溶酶体中,并表现出优异的光动力治疗疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号